journal article·2018-11-05Open access

Selol nanocapsules with a poly(methyl vinyl ether-co-maleic anhydride) shell conjugated to doxorubicin for combinatorial chemotherapy against murine breast adenocarcinoma in vivo

Rayane Ganassin, Frederico Hillesheim Horst, Nichollas Serafim Camargo, Sacha Braun Chaves, Paulo César Morais, Ewa Mosiniewicz-Szablewska, Piotr Suchocki, João Paulo Figueiró Longo, Ricardo Bentes Azevedo, Luis Alexandre Muehlmann

Abstract

Nanocapsules containing selol and doxorubicin (NCS-DOX) with an oily core of selol and a shell of poly(methyl vinyl ether-co-maleic anhydride) covalently conjugated to doxorubicin were developed in a previous work. In this study, these nanocapsules showed a similar antitumour effect in comparison to the free doxorubicin (DOX) treatment, but showed no evident DOX-related cardiotoxicity, as evidenced by serum creatine kinase-MB (CK-MB) activity. The histopathological analysis showed that the free DOX treatment induced more intense morphological damage to myocardial tissues in comparison to NCS-DOX treatment. Animals treated with free DOX presented important muscle fibre degradation and animals treated with NCS-DOX, heart tissue did not present signals of muscle fibre degeneration. These results indicate that the cardiotoxicity related to DOX is reduced when this drug is carried by the NCS-DOX. Noteworthy, biodistribution analyses showed that NCS-DOX accumulated more intensely in tumours than the free DOX. Thus, this study reinforces the importance of the development of nanocapsules as drug carriers for the treatment of cancer.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Cancer Treatment and Pharmacology · Bone health and treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasilia, Brasilia, Brazil;

Faculty of Ceilandia, University of Brasilia, Brasilia, Brazil;

Institute of Physics, University of Brasilia, Brasilia, Brazil;

School of Chemistry and Chemical Engineering, Anhui University, Hefei, PR China;

Institute of Physics, Polish Academy of Sciences, Warsaw, Poland;

Department of Bioanalysis and Drugs Analysis, Medical University of Warsaw, Warsaw, Poland

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico · Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

References (18)

Show source-provided references
1. 10.1016/j.addr.2010.03.01110.1016/j.addr.2010.03.011 ↗
2. 10.1016/j.nantod.2012.10.01010.1016/j.nantod.2012.10.010 ↗
3. 10.1038/natrevmats.2016.1410.1038/natrevmats.2016.14 ↗
4. 10.3109/21691401.2014.95172210.3109/21691401.2014.951722 ↗
5. 10.1080/21691401.2017.140802010.1080/21691401.2017.1408020 ↗
6. 10.1080/21691401.2017.137667510.1080/21691401.2017.1376675 ↗
7. Suchocki P · Oncol Rep · 2007 · 18 · 893
8. Praga C · Cancer Treat Rep · 1979 · 63 · 827
9. 10.2147/IJN.S5742010.2147/IJN.S57420 ↗
10. 10.1166/jbn.2016.220810.1166/jbn.2016.2208 ↗
11. 10.1186/s12951-014-0032-x10.1186/s12951-014-0032-x ↗
12. 10.1088/0957-4484/26/50/50510110.1088/0957-4484/26/50/505101 ↗
13. 10.2217/nnm-2017-009110.2217/nnm-2017-0091 ↗
14. 10.1093/annonc/mdh09710.1093/annonc/mdh097 ↗
15. 10.1016/j.ijcha.2015.11.00410.1016/j.ijcha.2015.11.004 ↗
16. 10.1016/j.jconrel.2014.12.03010.1016/j.jconrel.2014.12.030 ↗
17. Yuan F · Cancer Res · 1995 · 55 · 3752
18. Krishna R · Clin Cancer Res · 1999 · 5 · 2939